Comprehensive analysis of oncological outcomes of radical cystectomy for non-muscle invasive bladder cancer

T Takeshi Sano R Rikiya Taoka J Jun Miki R Ryoichi Saito W Wataru Fukuokaya Y Yoshiyuki Matsui S Shingo Hatakeyama T Takashi Kawahara A Ayumu Matsuda T Taketo Kawai M Minoru Kato T Tomokazu Sazuka F Fumihiko Urabe S Soki Kashima H Hirohito Naito Y Yoji Murakami M Makito Miyake K Kei Daizumoto Y Yuto Matsushita T Takuji Hayashi J Junichi Inokuchi Y Yusuke Sugino K Kenichiro Shiga N Noriya Yamaguchi S Shingo Yamamoto K Keiji Yasue T Takashige Abe S Shotaro Nakanishi K Katsuyoshi Hashine M Masato Fujii K Kiyoaki Nishihara H Hiroaki Matsumoto S Shuichi Tatarano K Koichiro Wada S Sho Sekito R Ryo Maruyama N Naotaka Nishiyama H Hiroyuki Nishiyama (University of Tsukuba, Tsukuba, Japan) H Hiroshi Kitamura T Takashi Kobayashi

Abstract

Abstract Owing to the rarity of radical cystectomy (RC) for non-muscle-invasive bladder cancer (NMIBC), information regarding oncological outcomes is limited. The aim was to conduct a comprehensive analysis of risk factors and survival outcomes following RC. This retrospective study included 435 patients who underwent RC for clinically diagnosed NMIBC at multiple institutions in Japan. The 5-year cancer-specific survival (CSS) rates were 97.4% for cTa, 93.3% for cTis, and 85.4% for cT1, respectively. Among 351 patients with cTa and cT1 disease, multivariable Cox proportional hazards analyses identified upstaging to ≥pT2 or pN+ disease as the most impactful risk factor associated with cancer-specific mortality (hazard ratio = 6.53; p  < 0.001). Neither neoadjuvant chemotherapy nor lymph node dissection (LND) exhibited a survival benefit in terms of CSS in this cohort; however, LND was occasionally indicative of pN+ disease, suggesting potential diagnostic value. The multivariable logistic regression analysis of preoperative variables identified tumour size (≥ 3 cm) as the lone risk factor associated with upstaging (odds ratio = 1.90; p  = 0.03). In the sensitivity analyses, tumour size ≥ 3 cm still trended toward an increased upstaging risk, without a statistically significant association. Although the prediction of upstaging remains highly challenging, RC should not be delayed when clinically indicated, even for patients diagnosed with NMIBC, particularly in those with large tumours.

Article Details

Volume / Issue Vol. 16, Issue 1
Published April 05, 2026
ISSN 2045-2322
Publisher Nature Portfolio

Journal Info

Scientific Reports

Nature Portfolio

ISSN: 2045-2322 Open Access Life Sciences

Authors (40)

T

Takeshi Sano

R

Rikiya Taoka

J

Jun Miki

R

Ryoichi Saito

W

Wataru Fukuokaya

Y

Yoshiyuki Matsui

S

Shingo Hatakeyama

T

Takashi Kawahara

A

Ayumu Matsuda

T

Taketo Kawai

M

Minoru Kato

T

Tomokazu Sazuka

F

Fumihiko Urabe

S

Soki Kashima

H

Hirohito Naito

Y

Yoji Murakami

M

Makito Miyake

K

Kei Daizumoto

Y

Yuto Matsushita

T

Takuji Hayashi

J

Junichi Inokuchi

Y

Yusuke Sugino

K

Kenichiro Shiga

N

Noriya Yamaguchi

S

Shingo Yamamoto

K

Keiji Yasue

T

Takashige Abe

S

Shotaro Nakanishi

K

Katsuyoshi Hashine

M

Masato Fujii

K

Kiyoaki Nishihara

H

Hiroaki Matsumoto

S

Shuichi Tatarano

K

Koichiro Wada

S

Sho Sekito

R

Ryo Maruyama

N

Naotaka Nishiyama

H

Hiroyuki Nishiyama

University of Tsukuba, Tsukuba, Japan

H

Hiroshi Kitamura

T

Takashi Kobayashi